Third Harmonic Bio, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €10.34K
    Gross profit
    -€10.34K
    SG&A expenses
    €21.85M
    R&D expenses
    €35.25M
    EBITDA
    -€54.18M
    D&A
    €31.88K
    EBIT
    -€57.12M
    Interest expenses
    €0.00
    EBT
    -€46.05M
    Tax expenses
    €0.00
    Net income
    -€46.05M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €3.02M
    Changes in working capital
    -€1.54M
    Operating cash flow
    -€35.92M
    Capex
    €8.62K
    Other investing cash flow
    €0.00
    Net investing cash flow
    -€8.62K
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €41.89M
    Debt repayment
    €0.00
    Other financing cash flow
    €43.50M
    Net financing cash flow
    €43.50M
    Foreign exchange effects
    €0.00
    Net change in cash
    €7.58M
    Cash at end of period
    €234.41M
    Free cash flow
    -€35.91M

    Balance sheet

    Cash and cash equivalents
    €234.01M
    Cash and short-term investments
    €234.01M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €3.78M
    Total current assets
    €237.78M
    Property, plant & equipment
    €2.55M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €755.58K
    Total non-current assets
    €3.31M
    Total assets
    €241.09M
    Accounts payable
    €2.31M
    Short-term debt
    €765.92K
    Other current liabilities
    €1.32M
    Total current liabilities
    €4.40M
    Long-term debt
    €1.82M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €1.82M
    Total liabilities
    €6.22M
    Common stock
    €4.31K
    Retained earnings
    -€151.22M
    Other equity
    €0.00
    Total equity
    €234.88M
    Total liabilities and shareholders' equity
    €241.09M

    Company information

    Market capitalization
    €209.01M
    Employees
    31
    Enterprise Value
    -€31.24M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -19.6% Even with peer group: -17.6%
    ROA
    -19.1% Much better than peer group: -474.3%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -17.2%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€1.49M

    Notifications